Hangzhou Tigermed Consulting Co., Ltd. (SZSE:300347) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Bin Shan M.D. | Senior Vice President, Chief Information Officer · Since at least Nov 6, 2026 |
| Chengcheng Yang | Senior Vice President, Chief Financial Officer · Since at least Nov 6, 2026 |
| Hao Wu | Co-President · Since at least Mar 27, 2025 |
| Jinlian Li | Senior Vice President, GM of China Innovative Drug Clinical Operations · Since at least Nov 6, 2026 |
| Lihua Chen | Senior Vice President, GM of the Biometrics BU · Since at least Nov 6, 2026 |
| Meng Song | Vice President, Chief Technology Officer · Since at least Nov 6, 2026 |
| Shuang Mo | Vice President, Chief Compliance Officer · Since at least Nov 6, 2026 |
| Sijia Hu | Senior Vice President, GM of SMO · Since at least Nov 6, 2026 |
| Tianrong Ji | Senior Vice President, Chief Investment Officer · Since at least Nov 6, 2026 |
| Xia Chen | Senior Vice President, Chief Medical Officer · Since at least Nov 6, 2026 |
| Xiaochun Cao | Co-founder, Director, Chair of the Board Executive Committee · Since at least Aug 28, 2026 |
| Xiaoping Ye | Co-founder, Chairman · Since at least Aug 28, 2026 |
| Yunjie(Shelley) Gong | Senior Vice President, Chief Quality Officer · Since at least Nov 6, 2026 |
| Zengyu Wen | Director, President · Since at least Sep 4, 2026 |
| Zhenyu Dai | Senior Vice President, Head of BD · Since at least Nov 6, 2026 |